SANOFI Pasteur has withdrawn
its marketing authorisation
application with the European
Medicines Agency, for Emerflu, a
pandemic influenza vaccine (split
virion, inactivated, adjuvanted) A/
Vietnam/1194/2004 NIBRG-14,
30 ˜g of haemagglutinin +
aluminium hydroxide adjuvant,
suspension for injection.
The move follows the finding by
Committee for Medicinal Products
for Human Use finding that there
was a lack of data on the vaccine’s
risk/benefit profile.
The EMA said the drug’s withdrawal
would not prejudice new
applications later down the track.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Dec 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Dec 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.